Sort
21,281 grants matching “influenza”
Oligoclonal T Cell Expansion and Rheumatoid Arthritis
$81,000Cornelia M Weyand · Emory University · R01 · FY2009 · AR
Rational design of M2e-FP conserved epitope-based universal influenza A vaccines
$81,000Lanying Du · New York Blood Center · R03 · FY2012 · AI
Inferring Shifts in Susceptibility and Cross Protection to Influenza from (Sub)typed Incidence Data
$81,000Wan Yang · Columbia University Health Sciences · R03 · FY2018 · AI
Rational design of M2e-FP conserved epitope-based universal influenza A vaccines
$81,000Lanying Du · New York Blood Center · R03 · FY2011 · AI
Inferring Shifts in Susceptibility and Cross Protection to Influenza from (Sub)typed Incidence Data
$81,000Wan Yang · Columbia University Health Sciences · R03 · FY2019 · AI
Administration
$80,968Laura Haynes · University Of Connecticut Sch Of Med/Dnt · P01 · FY2014 · AG
Glutamine Metabolism in Alveolar Macrophages following Influenza A Infection
$80,928Obada Shamaa · University Of Chicago · F32 · FY2023 · HL
Commensal bacteria as vehicles for robust mucosal vaccination against lung pathogens
$80,804Layla Barkal · Stanford University · F32 · FY2023 · HL
Genetic regulation and immunological function of ERAP2 haplotypes
$80,748Chun Jimmie Ye · University Of California, San Francisco · R01 · FY2021 · AI
Cell-free synthesis of influenza virus-like particles (VLPs) as prototyping platform for vaccine development and variant characterization
$80,715Irina V Novikova · Battelle Pacific Northwest Laboratories · R03 · FY2023 · AI
WAVE Regulatory Complex in Primary Immunodeficiency Disease and autoimmunity
$80,672Brian M Iritani · University Of Washington · R01 · FY2023 · AI
Task B26: In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses
$80,586Donald Smee · Utah State University · N01 · FY2017 · AI
Joint reagents, mice and viruses
$80,530Richard W Dutton · Univ Of Massachusetts Med Sch Worcester · P01 · FY2013 · AI
Market Integration and the Long-Term Health Impacts of Drought
$80,500Taryn Dinkelman · Dartmouth College · R03 · FY2012 · HD
Role of sialylated LPS in H. influenzae otitis media
$80,500Boston Medical Center · R21 · FY2003 · DC
Role of sialylated LPS in H. influenzae otitis media
$80,500Boston Medical Center · R21 · FY2002 · DC
Mechanism of pulmonary vascular wall thickening in COVID-19
$80,496Yuichiro Justin Suzuki · Georgetown University · R03 · FY2021 · AG
VACCINE AND TREATMENT EVALUATION UNITS: PHASE I INFLUENZA VACCINE CLINICAL TRIAL
$80,427Karen Kotloff · University Of Maryland Baltimore · N01 · FY2017 · AI
Activity-based probes for targeted imaging and treatment of bacterial otitis media
$80,224Emily Clark Woods · Stanford University · F32 · FY2025 · AI
The effects of polyparasitism on vaccine response
$80,174Indu Malhotra · Case Western Reserve University · R03 · FY2011 · HD
RAPID: Collaborative Research: Operational COVID-19 Forecasting with Multi-Source Information
$80,169Yulia Gel · University Of Texas At Dallas · · FY2020 · MPS
Development of drugs that target the M2 proton channel from the influenza A Virus
$80,144William F Degrado · University Of Pennsylvania · U01 · FY2009 · AI
Surveillance & Response to Avian & Pandemic Influenza by Nat'l Hlth Auth outside
$80,000Zakhashvili Khatuna · National Center/Disease Ctrl/Med Stats · U51 · FY2011 · CI
Immune potentiation to improve neonatal and pediatric vaccines
$80,000Naveen Surendran · Rochester General Hospital (Ny) · R03 · FY2016 · AI
STRUCTURE OF INFLUENZA AND OTHER ENVELOPED VIRUSES
$80,000University Of Medicine And Dentistry Of New Jersey/Newar · · FY1974